Skip to main content

7 Result(s)

within Article Remove this filter Yoshimichi Ueda Remove this filter English Remove this filter Oncology Remove this filter

and

  1. Article

    Open Access

    FDG-PET/CT and diffusion-weighted imaging for resected lung cancer: correlation of maximum standardized uptake value and apparent diffusion coefficient value with prognostic factors

    Diffusion-weighted magnetic resonance imaging (DWI) is useful for detecting malignant tumors and the assessment of lymph nodes, as FDG-PET/CT is. But it is not clear how DWI influences the prognosis of lung ca...

    Katsuo Usuda, Aika Funasaki, Atsushi Sekimura, Nozomu Motono… in Medical Oncology (2018)

    Download PDF (1575 KB) View Article

  2. No Access

    Article

    Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma

    Patients with the same pathological stage of lung adenocarcinoma display marked variability in postoperative recurrence. The aim of this study was to predict the postoperative prognosis in patients with small-...

    Kotaro Higashi, Tsutomu Sakuma, Kengo Ito… in European Journal of Nuclear Medicine and M… (2009)

  3. No Access

    Article

    11C-acetate PET imaging of lung cancer: comparison with 18F-FDG PET and 99mTc-MIBI SPET

    Recently carbon-11 acetate (AC) positron emission tomography (PET) has been reported to be of clinical value for the diagnosis of cancer that is negative on fluorine-18 fluorodeoxyglucoce (FDG) PET. We investi...

    Kotaro Higashi, Yoshimichi Ueda… in European Journal of Nuclear Medicine and M… (2004)

  4. No Access

    Article

    Correlation of Glut-1 glucose transporter expression with [18F]FDG uptake in non-small cell lung cancer

    Positron emission tomography (PET) with [18F]2-fluoro-2-deoxy-D-glucose (FDG) may show negative results for bronchioloalveolar lung carcinoma. We investigated the correlation of Glut-1 glucose transporter expres...

    Kotaro Higashi, Yoshimichi Ueda, Aya Sakurai… in European Journal of Nuclear Medicine (2000)

  5. No Access

    Article

    Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone

    Alterations of tumour suppressor genes are considered crucial steps in the development of human cancers. Expressions of p53 protein, a product of the tumour suppressor gene altered most commonly in human cance...

    Yoshimichi Ueda, Barbara Dockhorn-Dworniczak… in Journal of Cancer Research and Clinical On… (1993)

  6. No Access

    Article

    Immunohistochemical localization of collagenous proteins in cartilaginous tumors: characteristic distribution of type IX collagen

    The distinctive tissue localization of collagen types, particularly of type IX collagen in human cartilaginous tumors (10 cases of enchondroma and 15 cases of chondrosarcoma including 3 cases of secondary chon...

    Atsuhiro Kawashima, Yoshimichi Ueda… in Journal of Cancer Research and Clinical On… (1993)

  7. No Access

    Article

    Cellular variant of extraskeletal myxoid chondrosarcoma of abdominal wall — a case report with comparative immunohistochemical study on cartilaginous collagenous proteins in various myxoid mesenchymal tumors

    A rare cellular variant of recurrent extraskeletal myxoid chondrosarcoma occurring in the right lower abdominal wall of a 70-year-old man, is presented with emphasis on a characteristic distribution pattern of...

    Yoshimichi Ueda, Yasunori Okada… in Journal of Cancer Research and Clinical On… (1992)